CO
Coeptis Therapeutics Holdings, Inc.
COEPW · NASDAQ
$0.01 +0.00% (+$0.00)
Market Cap $64.7K
P/E Ratio -
Div. Yield -
ROE 123.49%
Bulios Fair Price
$0.01
3.8% downside
Current Price
$0.01
Undervalued Fair Value Overvalued
According to Bulios Fair Price, COEPW is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
5/9Valuation
100 /100
Cheap P/S 0.05x
P/B 0.00x
P/E N/A
Growth
-
N/A EPS growth N/A
Rev. growth N/A
Book val. growth N/A
Profitability
0 /100
Weak Gross margin 9.69%
Net margin 874.29%
FCF margin 631.16%
Quality
1 /100
Poor ROIC 118.59%
ROE 123.49%
Asset turnover 0.08x
Debt
80 /100
Low Debt/Equity 0.01x
Current ratio 4.16x
Net debt/EBITDA 0.48x
Stability
1 /100
Unstable Beta 2.42x
EPS volatility 1,828.74%
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about COEPW
Online
Sector
Healthcare
Industry
Biotechnology
CEO
David Mehalick
Employees
4
Headquarters
Wexford